A pharmaceutical company for womxnThe term womxn includes all cis, trans and non-binary people.
MD, PhD André Ulmann is a renowned entrepreneur
in the field of womxnThe term womxn includes all cis, trans and non-binary people.’s health.
Having set up various pharmaceutical companies, he founded, in particular, HRA in 1996, which designed and
marketed the first “morning after pill”.
Always at the forefront of societal developments, André Ulmann founded CEMAG Care to meet the unmet medical needs of all womxnThe term womxn includes all cis, trans and non-binary people., regardless of the obstacles.
Our Pharmaceutical Company
We are a dynamic, motivated team! Our projects are important to us: we are the first users of our products.
Our everyday goal is to give womxnThe term womxn includes all cis, trans and non-binary people. control of their bodies at every stage of their lives.
What we do
RELATIONSHIPS OF TRANSPARENCY
CEMAG Care acts by respecting the rules of ethics and the principle of transparency of interests in application of the French Act of December 29, 2011 and the Decree of May 21, 2013. CEMAG Care publishes all granted advantages and remunerations in the frame of agreements signed with Healthcare professionals on the website of the French Ministry of Social Affairs and Health:
QUALITY OF PROMOTIONAL INFORMATION
CEMAG Care is a pharmaceutical company committed to innovation, in full respect of the regulatory rules. It aims at building strong and trustful relationships with its partners.
CEMAG Care’s main mission is to bring to patients healthcare products of quality, safety and efficacy in many therapeutic areas.
In the frame of its constant improvement politic, CEMAG Care has set up a quality of promotional information politic
Through this politic, CEMAG Care commits to improve quality and transparency of professional medical appointments. By adhering to the charter of information by canvassing or prospecting for the promotion of medicines and the Reference Tool for certifying the activity of informing via prospecting aimed at promoting medicines, staff dedicated to this information activity is available to inform healthcare professionals about Ethics rules and to answer any question they might have.
- Information by canvassing or prospecting for the promotion of medicines Charter (October 2014) : Medical visit Charter
- Reference Tool for certifying the activity of informing via prospecting aimed at promoting medicines (March 2017) : Reference Tool
In the frame of medical appointments, staff dedicated to promotional activity might gather and computer process professional healthcare data in a strictly professional manner. In compliance with French Data-Protection Act of January 6, 1978, healthcare professionals have the right to access and correct data concerning them by contacting firstname.lastname@example.org.